Xatolos@reddthat.com to News@lemmy.world · 6 months agoFDA’s review of MDMA for PTSD highlights study bias and safety concernsarstechnica.comexternal-linkmessage-square43fedilinkarrow-up1164arrow-down111cross-posted to: [email protected]
arrow-up1153arrow-down1external-linkFDA’s review of MDMA for PTSD highlights study bias and safety concernsarstechnica.comXatolos@reddthat.com to News@lemmy.world · 6 months agomessage-square43fedilinkcross-posted to: [email protected]
minus-squaregandalf_der_12te@discuss.tchncs.delinkfedilinkarrow-up2·6 months agoYeah, I guess you have a point.
Yeah, I guess you have a point.